Idiopathic nodular glomerulosclerosis in a chronic marijuana user; a case report and review of the literature by Mollaee, Mehri et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Pathology, Anatomy, and Cell
Biology Faculty Papers
Department of Pathology, Anatomy, and Cell
Biology
12-1-2017
Idiopathic nodular glomerulosclerosis in a chronic
marijuana user; a case report and review of the
literature
Mehri Mollaee
Thomas Jefferson University, mehri.mollaee@jefferson.edu
Tibor Fülöp
University of Mississippi
Sohil Abdul Salim
University of Mississippi
Seyed Mehrdad Hamrahian
Thomas Jefferson University, Seyed.Hamrahian@jefferson.edu
Let us know how access to this document benefits you
Follow this and additional works at: https://jdc.jefferson.edu/pacbfp
Part of the Nephrology Commons, and the Pathology Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Pathology, Anatomy, and Cell Biology Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more
information, please contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Mollaee, Mehri; Fülöp, Tibor; Abdul Salim, Sohil; and Hamrahian, Seyed Mehrdad, "Idiopathic
nodular glomerulosclerosis in a chronic marijuana user; a case report and review of the literature"
(2017). Department of Pathology, Anatomy, and Cell Biology Faculty Papers. Paper 228.
https://jdc.jefferson.edu/pacbfp/228
Idiopathic nodular glomerulosclerosis in a chronic marijuana 
user; a case report and review of  the literature
www.nephropathol.com               DOI: 10.15171/jnp.2017.46                                          J Nephropathol. 2017;6(4):278-281
Journal of  Nephropathology 
*Corresponding author: Mehrdad Hamrahian, Email : seyed.hamrahian@jefferson.edu
Mehri Mollaee1, Tibor Fülöp2, Sohil Abdul Salim2, Mehrdad Hamrahian3*
1Department of  Pathology, Thomas Jefferson University; Philadelphia, PA, USA
2Department of  Medicine - Nephrology, University of  Mississippi; Jackson, MS, USA
3Department of  Medicine - Nephrology, Thomas Jefferson University; Philadelphia, PA, USA
C
as
e 
R
ep
or
t
Implication for health policy/practice/research/medical education:
Idiopathic nodular glomerulosclerosis (ING) is a rare distinct clinicopathologic entity that has been linked to heavy tobacco 
smoking, chronic hypertension, obesity and insulin resistance. Its association with marijuana use is unknown. We report a case 
of  biopsy-proved ING in the absence of  pre-existing history of  diabetic nephropathy (DN) and heavy smoking. This report 
addresses the possible accentuation of  tobacco use risk by marijuana.
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Background: Nodular glomerulosclerosis is a characteristic histological finding of diabetic 
nephropathy (DN) with thickened glomerular basement membrane (GBM) and hyalinized 
arterioles. Idiopathic nodular glomerulosclerosis (ING), a rare distinct clinicopathologic 
entity, is the term used to denote classic DN confirmed by light microscopy, immuno-
fluorescence, and electron microscopy in the absence of diabetes mellitus (DM). ING 
has been linked to heavy tobacco smoking, chronic hypertension, obesity and insulin 
resistance. Its association with marijuana use is unknown. 
Case Presentation: We report a case of biopsy-proved ING in the absence of pre-existing 
history of DM and heavy smoking. This report addresses the possible accentuation of 
tobacco use risk by marijuana.
Conclusions: This report addresses the possible accentuation of tobacco use risk by marijuana.
ABSTRACT
1. Introduction
Nodular glomerulosclerosis, a histologic pattern of 
nodular mesangial sclerosis with glomerular lobulari-
ty, is the classic lesion of  diabetic nephropathy (DN) 
(1). The differential diagnosis for nodular glomerulo-
sclerosis is broad and includes membranoproliferative 
glomerulonephritis, amyloidosis, monoclonal immuno-
globulin deposition disease, fibrillary or immunotac-
toid glomerulonephropathy, glomerulopathy associat-
ed with a chronic hypoxic state (e.g., Takayasu’s arteri-
tis), and idiopathic nodular glomerulosclerosis (ING).
ING is rare and remains a diagnosis of  exclusion (2). 
The defining pathological features of  ING are dif-
fuse and nodular mesangial sclerosis accompanied by 
glomerular basement membrane (GBM) thickening, 
glomerulomegaly, and arteriolosclerosis. It is strongly 
associated with hypertension and heavy smoking. We 
report a case of  ING in a chronic marijuana user with 
insignificant history of  tobacco use and no history of 
DM.
2. Case Report 
A 36-year-old African-American female with insignifi-
cant medical history presented to the emergency room 
with chief  complaint of  daily vomiting for one week, 
poor appetite, and unintentional weight loss of  35 kg 
over one year. She also had been experiencing migraine 
headaches and was taking ibuprofen chronically. Nine 
years earlier, she had taken antihypertensive medication 
for six months after her last pregnancy with no his-
tory of  preeclampsia or chronic hypertension (HTN) 
known prior to the pregnancy. Despite systolic blood 
pressure (BP) readings of  150-170 mm Hg recorded 
5 months prior to this admission; she was on no anti-
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hypertensive medication. She had no diabetes mellitus 
(DM). Her family history was negative for autoimmune 
diseases, but her mother and sister both had HTN and 
DM. She had no allergies and denied the use of  any 
herbal remedies. She had started smoking tobacco ciga-
rettes socially at age 25 and smoked up to five cigarettes 
per day before quitting a year ago. She had significant 
history of  using marijuana starting 10 years ago and 
had been smoking twice a day for the last five years 
prior to admission. She denied use of  other illicit drugs 
or heavy drinking. 
On examination, she was afebrile and her BP measured 
195/103 mm Hg with a regular pulse of  103 beats/
minute. Oxygen saturation was 100% on room air. Her 
body mass index was 29 kg/m2. Physical examination 
was otherwise unremarkable except for pale conjuncti-
va. Laboratory parameters showed microcytic anemia 
with hemoglobin of  4.9 g/dL and iron saturation of 
4% with a ferritin level of  13 ng/mL. Stool was neg-
ative for occult blood. Erythrocyte sedimentation rate 
was 66 mm/h. Her urine and blood culture were both 
negative. Her renal function was as follows: blood urea 
nitrogen 87 mg/dL; creatinine 10.9 mg/dL (1.0 mg/
dL 5 years earlier); bicarbonate 12 mEq/L; potassium 
5.1 mEq/L. Phosphorus was 8.3 mg/dL with elevat-
ed parathyroid hormone of  1,729 pg/mL. Urinalysis 
showed 3+ protein at specific gravity of  1.008 with-
out any red blood cells. Spot random urine revealed 
a protein to creatinine ratio of  384/77 mg/dL with 
a serum albumin of  3.6 g/dL. Total cholesterol was 
151 mg/dL with low-density lipoprotein being 82 mg/
dL. Anti-neutrophil antibody, serum complement lev-
els, hepatitis and HIV screening were all negative or 
normal. Fasting blood glucose was normal, and HgbA1c 
was 5.3%. Urine drug screen was positive for canna-
binoid (delta-9-tetrahydrocannabinol [TCH], and oth-
er derivatives). Renal ultrasound demonstrated a right 
kidney size of  10.4 cm and left kidney of  10.8 cm in 
length with increased cortical echogenicity without hy-
dronephrosis. Her echocardiography showed moderate 
concentric left ventricular hypertrophy, normal ejection 
fraction, and moderate pulmonary hypertension. Renal 
biopsy was done for unchanged renal function despite 
volume resuscitation with packet red blood cell trans-
fusions and blood pressure control. 
2.1. Renal biopsy 
On light microscopy, the glomeruli showed extensive 
diffuse and nodular glomerulosclerosis (Figure 1). 
Several of  the GBM appeared thickened with a few 
glomeruli contained intra-capillary hyaline. There was 
no mesangial/endocapillary cell proliferation or dou-
ble contouring, and no immune complex deposits were 
identified. One glomerulus showed wrinkling of  the 
GBM consistent with ischemic change. There was dif-
fuse interstitial fibrosis and tubular atrophy extending 
throughout the cortex. Several arterioles showed hya-
line arteriolosclerosis. Immunofluorescence was only 
positive for segmental IgM in 2/8 glomeruli, but other-
wise negative for human IgG (heavy and light chains), 
IgG (gamma chain), IgA, kappa light chain, lambda 
light chain, C1q, C3, C4, albumin, and fibrinogen. Elec-
tron microscopy of  two of  glomeruli showed widening 
of  the mesangial areas by mesangial matrix (diffuse glo-
merulosclerosis) and areas of  nodular glomeruloscle-
rosis. The GBM was thickened with a mean thickness 
of  616 ±- 50 nm. The visceral epithelial cells showed 
large areas of  foot processes effacement (Figure 2). 
There was no immune complex deposition or deposits 
compatible with light chain seen. There was no fibril-
lary material compatible with amyloid or fibrillary glo-
merulonephritis.
3. Discussion
Once considered a diagnosis of  exclusion, ING is a 
rare distinct clinicopathologic entity (2). It is predom-
inantly described in elderly Caucasian individuals and 
Figure 1. Light microscopy of  idiopathic nodular glomerulosclerosis 
(H&E original magnification × 200): The glomerulus shows 
extensive diffuse nodular glomerulosclerosis.
Figure 2. Electron microscopy of  idiopathic nodular 
glomerulosclerosis (original magnification × 14300): There is 
widening of  the mesangial areas by increased mesangial matrix and 
thickened glomerular capillary basement membrane. There is diffuse 
foot process effacement.
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is linked to heavy smoking, hypertension, and obesity 
(3,4). Patients usually present with renal insufficiency 
and proteinuria of  variable degrees. The pathogenesis 
involves the interplay of  hypertension, heavy smoking, 
increased glomerular extracellular matrix (ECM) and 
angiogenesis (5). 
Tobacco smoking has a negative impact on renal func-
tion, particularly in a patient with hypertension, DM, 
and primary renal disease (6). It increases the risk of  al-
buminuria, progression to proteinuria, and renal func-
tional impairment, particularly in men and the elderly. 
The pathophysiologic mechanisms include the forma-
tion of  advanced glycation end-products (AGEs) by 
glycotoxins, induction of  oxidative stress, angiogenesis, 
and altered intrarenal hemodynamics (7,8). Induction 
of  oxidative stress by free radicals contained in ciga-
rette smoke and directly by AGE increases ECM. AGE 
alters ECM by promoting mesangial cell synthesis of 
fibrogenic cytokines, platelet-derived growth factor, 
insulin growth factor (IGF) and transforming growth 
factor-beta (TGF-β) (9). Furthermore, smoking di-
rectly and indirectly, through chronic hypoxia, leads to 
sympathetic activation and stimulation of  the renin-an-
giotensin aldosterone system; it promotes increased 
renal vascular resistance, decreased renal plasma flow, 
hypertension, and ECM production. In addition, AGE 
interacts with its receptor RAGE, which is predomi-
nantly expressed in podocytes. Podocytes play a crucial 
role in the pathogenesis of  glomerulosclerosis and pre-
vent proteinuria through a complex regulation of  actin 
cytoskeleton in their foot processes. They are insulin 
responsive cells and their function, structure, and sur-
vival are under the control of  insulin stimulation (10). 
Respectively, podocyte-specific insulin resistance is 
considered a potential mechanism of  glomerular kid-
ney damage (11). 
Our patient presented with advanced renal insuffi-
ciency, nephrotic range proteinuria, and untreated hy-
pertension of  unknown duration. Her renal function 
remained impaired despite volume resuscitation with 
packed red blood cells and blood pressure control. 
Kidney biopsy findings of  diffuse and nodular glomer-
ulosclerosis, GBM thickening, and arteriolar hyalinosis 
favored a diagnosis of  diabetic glomerulosclerosis, but 
there was no evidence of  diabetes or impaired glucose 
tolerance on biochemical testing and available records 
from the past. There were no immune deposits on 
immunofluorescence and no fibrillar or microtubular 
structures on electron microscopy. The patient’s nega-
tive serology tests led us to diagnose ING with features 
of  hypertensive vascular changes. Interestingly, though 
she was not a heavy tobacco smoker, she used marijua-
na daily.
Cannabis is the most widely used illicit drug after to-
bacco and alcohol. There is a rising interest in its ther-
apeutic use for chemotherapy-induced nausea and 
vomiting, HIV-associated anorexia, neuropathic pain 
in multiple sclerosis, pain associated with rheumatoid 
arthritis, fibromyalgia, and cancer (12). Respectively, 
its safety is an emerging source of  concern. Marijuana 
is an ill-defined conglomerate of  chemicals. Its short- 
and long-term adverse effects are difficult to evaluate 
because often there is a concurrent consumption of  to-
bacco and alcohol. Delta-9-tetrahydrocannbinol (TCH) 
is mainly metabolized in the liver by cytochrome P-450 
and appears to be responsible for the principle toxi-
cological effect. Its effects are dose dependent and 
range from serious psychological to somatic disorders, 
including tachycardia and dyspnea progressing to ap-
nea and death. Excessive use of  marijuana, as expe-
rienced by our patient, could result in a cyclic vomit-
ing, a condition called ‘cannabinoid hyperemesis syn-
drome’ (13). The long-term cardiovascular effects and 
associated health risks with chronic use of  marijuana 
remain unknown. Acutely, there is a dose-dependent 
tachycardia and modest increase in blood pressure via 
centrally mediated beta-sympathetic stimulation and 
reduced parasympathetic activity (14). Decreased vas-
cular resistance associated with increased blood flow 
to the extremities may cause postural hypotension and 
even syncope (15). Although it is difficult to determine 
the effect of  marijuana in our patient’s renal pathology 
and the diagnosis of  ING, her insignificant smoking 
history strongly suggests that chronic use of  marijuana 
has played a significant role or may have accentuated 
the risk of  development of  ING associated with to-
bacco use. Smoking causes carbon monoxide-induced 
hypoxia and, compared to one tobacco cigarette, a mar-
ijuana cigarette increases the carboxyhemoglobin levels 
by fivefold resulting in tissue hypoxia (16). Moreover, 
cases of  arteritis associated with marijuana use leading 
to ischemia have been described (17). Finally, marijuana 
produces oxidative stress increasing ECM via TGF-be-
ta and IGF as outlined above (18).
Our case is unique in that the patient was a young Afri-
can American female with relatively insignificant tobac-
co smoking history but chronic daily marijuana use for 
over 10 years. This contrasts with the two biggest case 
series reported by Columbia University (1996-2001) 
(4), where most patients were old, white, heavy-smok-
ing males and the University of  Texas/Houston (1998-
2007) (3) where most patients were females. This gen-
der distribution in the two biggest case series could be 
due to the sampling period with smoking becoming 
more prevalent among females over the last decades. 
4. Conclusions
The pathogenesis of  ING remains unclear and the 
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prognosis is poor. It involves the interplay of  hyper-
tension, obesity, insulin resistance and heavy smoking. 
Chronic use of  marijuana may accentuate the tobacco 
risk. Although illegal in many countries, marijuana use 
is widespread, especially among the adolescents and 
young adults, for its euphoric effects. With the rising 
therapeutic use of  cannabis-based medicine, it is im-
portant that physicians be equally vigilant about the 
possible long-term renal toxicity effects of  marijuana 
beyond the acute kidney injury seen with cannabinoid 
hyperemesis syndrome.
Authors’ contribution
MM reviewed pathology literature and wrote the first 
draft. SAS reviewed nephrology literature and helped 
with first draft. TF edited the manuscript and took care 
of  the patient after hospital discharge. MH did take 
care of  the patient during the hospitalization and is the 
senior author.
Conflicts of  interest
Authors have no relevant conflict of  interest to disclose.
Informed consent
A written informed consent was obtained from the pa-
tient to report this case. 
Funding/Support
None.
References 
1. Paola Fioretto, Michael Mauer. Histology of  diabetic 
nephropathy. Semin Nephrol. 2007;27(2):195-207. doi: 
10.1016/j.semnephrol.2007.01.012.
2. Herzenberg, Holden JK, Singh S, Magil AB. Idiopathic 
nodular glomerulosclerosis. Am J Kidney Dis 
1999;34(3):560-4. doi: 10.1053/AJKD03400560.
3. Kuppachi S, Idris N, Chander PN, Yoo J. Idiopathic 
nodular glomerulosclerosis in a non-diabetic 
hypertensive smoker: case report and review of 
literature. Nephrol Dial Transplant. 2006;21(12):3571–
5. doi: 10.1093/ndt/gfl422.
4. Li W, Verani RR. Idiopathic nodular glomerulosclerosis: 
a clinicopathologic study of  15 cases. Human 
Pathol 2008;39(12):1771-6. doi: 10.1016/j.
humpath.2008.05.004.
5. Markowitz GS, Lin J, Valeri AM, Avila C, Nasr SH, 
D’Agati VD. Idiopathic nodular glomerulosclerosis is a 
distinct clinicopathologic entity linked to hypertension 
and smoking. Hum Pathol 2002;33(8):826-35. doi: 
10.1053/hupa.2002.126189.
6. Orth SR. Smoking and the kidney. J Am Soc 
Nephrol. 2002;13:1663-72. doi: 10.1097/01.
ASN.0000018401 .82863 .FD 
7. Cerami C, Founds H, Nicholl I, Mitsuhashi T, Giordano 
D, Vanpatten S, et al. Tobacco smoke is a source of 
toxic reactive glycation products. Proc Natl Acad Sci U 
S A. 1997;94(25):13915-20.
8. Nasr SH, D’Agati VD. Nodular glomerulosclerosis 
in the nondiabetic smoker. J Am Soc Nephrol 
2007;18(7):2032-6. doi: 10.1681/ASN.2006121328.
9. Throckmorton DC, Brogden AP, Min B, Rasmussen 
H, Kashgarian M. PDGF and TGF-beta mediate 
collagen production by mesangial cells exposed to 
advanced glycosylation end products. Kidney Int. 
1995;48(1):111-17. 
10. Coward RJ, Welsh GI, Yang J, Tasman C, Lennon 
R, Koziell A, et al. The human glomerular podocyte 
is a novel target for insulin action. Diabetes. 
2005;54(11):3095-102. 
11. Welsh GI, Hale LJ, Eremina V, Jeansson M, Maezawa 
Y, Lennon R, et al. Insulin signaling to the glomerular 
podocyte is critical for normal kidney function. 
Cell Metab. 2010;12(4):329-40. doi: 10.1016/j.
cmet.2010.08.015.
12. Institute of  Medicine. Marijuana and Medicine: 
Assessing the Science Base. Washington DC: National 
Academies Press; 1999. 
13. Sontineni SP, Chaudhary S, Sontineni V, Lanpa 
SJ. Cannabinoid hyperemesis syndrome: clinical 
diagnosis of  an underrecognised manifestation 
of  chronic cannabis abuse. World J Gastroenterol. 
2009;15(10):1264-6. doi: 10.3748/wjg.15.1264.
14. Sidney S. Cardiovascular consequences of  marijuana 
use. J Clin Pharmacol. 2002;42(S1):64S-70S. doi: 
10.1002/j.1552-4604.2002.tb06005.
15. Benowitz NL, Rosenberg J, RogersW, Bachman J, 
Jones RT. Cardiovascular effects of  intravenous 
Delta-9-tetrahydrocannabinol: autonomic nervous 
mechanisms. Clin Pharmacol Ther. 1979;25(4):440-6.
16. Wu T, Tashkin D, Djahed B, Rose J. Pulmonary hazards 
of  smoking marijuana as compared with tobacco. 
N Engl J Med. 1988;318(6):347-51. doi: 10.1056/
NEJM198802113180603.
17. Nahas GG. Cannabis arteritis. N Engl J Med. 
1971;284(2):113. doi: 10.1056/NEJM197101142840226.
18. Sarafian TA, Magallanes JA, Shau H, Tashkin D, Roth 
MD. Oxidative stress produced by marijuana smoke: an 
adverse effect enhanced by cannabinoids. Am J Respir 
Cell Mol Biol. 1999;20(6):1286-93. doi: 10.1165/
ajrcmb.20.6.3424.
Copyright © 2017 The Author(s); Published by Society of  Diabetic Nephropathy Prevention. This is an open-access article 
distributed under the terms of  the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
